Arcutis Biotherapeutics
ARQT
ARQT
94 hedge funds and large institutions have $1.35B invested in Arcutis Biotherapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
18% more capital invested
Capital invested by funds: $1.15B → $1.35B (+$202M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.4% less ownership
Funds ownership: 93.91% → 93.51% (-0.4%)
Holders
94
Holding in Top 10
4
Calls
$3.69M
Puts
$347K
Top Buyers
| 1 | +$37.8M | |
| 2 | +$31.6M | |
| 3 | +$25.4M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$22.6M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$18.9M |
Top Sellers
| 1 | -$32.8M | |
| 2 | -$12.6M | |
| 3 | -$5.88M | |
| 4 |
Millennium Management
New York
|
-$4.2M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$3.55M |